Multi-center clinical trial for diagnostic value of sentinel node biopsy to detect lymph node metastasis in gastric cancer

Multi-center clinical trial for diagnostic value of sentinel node biopsy to detect lymph node metastasis in gastric cancer - Sentinel biopsy for gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000476

Enrollment

500

Registered

2006-09-01

Start date

2004-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

sentinel node mapping

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: cT1, T2N0 gastric cancer Diameter of primary lesion < 4.0 cm No indication for endoscopic treatments based on guidelines recommended by Japan Gastric Cancer Association Single lesion No previous treatment for gastric cancer No previous gastric surgery Informed consent

Exclusion criteria

Exclusion criteria: Pregnancy Drug allergy Asthma

Design outcomes

Primary

Measure	Time frame
Sensitivity to detect lymph node metastasis based on sentinel node biopsy	—

Secondary

Measure	Time frame
Detection rate of sentinel nodes, The distribution and the number of sentinel nodes Incidence of adverse effect	—

Countries

Japan

Contacts

Public ContactYuko Kitagawa

Keio University, School of Medicine Department of Surgery

kitagawa@sc.itc.keio.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026